CMR myocardial tissue characterization in a mouse model of doxorubicin-induced cardiotoxicity

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1532-429X
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
CMR myocardial tissue characterization in a mouse model of doxorubicin-induced cardiotoxicity ; volume:17 ; number:1 ; day:3 ; month:2 ; year:2015 ; pages:1-3 ; date:12.2015
Journal of cardiovascular magnetic resonance ; 17, Heft 1 (3.2.2015), 1-3, 12.2015

Urheber
Allen, Bradley D.
Beteiligte Personen und Organisationen
Anderle, Micah
Misener, Sol
Murtagh, Gillian
Furiasse, Nicholas
Akhter, Nausheen
Procissi, Daniele
Carr, James C.
SpringerLink (Online service)

DOI
10.1186/1532-429X-17-S1-Q135
URN
urn:nbn:de:1111-2016032322928
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 11:00 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Allen, Bradley D.
  • Anderle, Micah
  • Misener, Sol
  • Murtagh, Gillian
  • Furiasse, Nicholas
  • Akhter, Nausheen
  • Procissi, Daniele
  • Carr, James C.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice

Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice

Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat

Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat

Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy

Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy

Empagliflozin prevents doxorubicin-induced myocardial dysfunction

Empagliflozin prevents doxorubicin-induced myocardial dysfunction

Sex Differences in Doxorubicin‐Induced Cardiotoxicity: Insights from Transcriptome Analysis

Sex Differences in Doxorubicin‐Induced Cardiotoxicity: Insights from Transcriptome Analysis

Protective effect of silymarin on doxorubicin-induced cardiotoxicity in rats

Protective effect of silymarin on doxorubicin-induced cardiotoxicity in rats

The significance of the apelinergic system in doxorubicin-induced cardiotoxicity

The significance of the apelinergic system in doxorubicin-induced cardiotoxicity

Tripartite motif 25 ameliorates doxorubicin-induced cardiotoxicity by degrading p85α

Tripartite motif 25 ameliorates doxorubicin-induced cardiotoxicity by degrading p85α

Shikonin alleviates doxorubicin-induced cardiotoxicity via Mst1/Nrf2 pathway in mice

Shikonin alleviates doxorubicin-induced cardiotoxicity via Mst1/Nrf2 pathway in mice

The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity

The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity

Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity

Cardiomyocyte-specific disruption of Cathepsin K protects against doxorubicin-induced cardiotoxicity

PFKM inhibits doxorubicin-induced cardiotoxicity by enhancing oxidative phosphorylation and glycolysis

PFKM inhibits doxorubicin-induced cardiotoxicity by enhancing oxidative phosphorylation and glycolysis

Verbundene Objekte